267 related articles for article (PubMed ID: 33658999)
1. CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function.
Bhamidipati K; Silberstein JL; Chaichian Y; Baker MC; Lanz TV; Zia A; Rasheed YS; Cochran JR; Robinson WH
Front Immunol; 2020; 11():626820. PubMed ID: 33658999
[TBL] [Abstract][Full Text] [Related]
2. CD4
Umeda M; Koga T; Ichinose K; Igawa T; Sato T; Takatani A; Shimizu T; Fukui S; Nishino A; Horai Y; Hirai Y; Kawashiri SY; Iwamoto N; Aramaki T; Tamai M; Nakamura H; Yamamoto K; Abiru N; Origuchi T; Ueki Y; Kawakami A
Clin Immunol; 2018 Feb; 187():50-57. PubMed ID: 29031579
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
4. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity.
Wong CK; Wong PT; Tam LS; Li EK; Chen DP; Lam CW
J Clin Immunol; 2010 Jan; 30(1):45-52. PubMed ID: 19774453
[TBL] [Abstract][Full Text] [Related]
5. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
6. CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
Akatsu C; Tsuneshige T; Numoto N; Long W; Uchiumi T; Kaneko Y; Asano M; Ito N; Tsubata T
J Autoimmun; 2024 Jun; 146():103245. PubMed ID: 38754236
[TBL] [Abstract][Full Text] [Related]
7. CXCL13/CXCR5 signaling enhances BCR-triggered B-cell activation by shaping cell dynamics.
Sáez de Guinoa J; Barrio L; Mellado M; Carrasco YR
Blood; 2011 Aug; 118(6):1560-9. PubMed ID: 21659539
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus.
Dörner T; Szelinski F; Lino AC; Lipsky PE
RMD Open; 2020 Jul; 6(2):. PubMed ID: 32675278
[TBL] [Abstract][Full Text] [Related]
9. Type I and II interferons commit to abnormal expression of chemokine receptor on B cells in patients with systemic lupus erythematosus.
Yoshikawa M; Nakayamada S; Kubo S; Nawata A; Kitanaga Y; Iwata S; Sakata K; Ma X; Wang SP; Nakano K; Saito K; Tanaka Y
Clin Immunol; 2019 Mar; 200():1-9. PubMed ID: 30576845
[TBL] [Abstract][Full Text] [Related]
10. Defective FcgammaRIIb1 signaling contributes to enhanced calcium response in B cells from patients with systemic lupus erythematosus.
Enyedy EJ; Mitchell JP; Nambiar MP; Tsokos GC
Clin Immunol; 2001 Nov; 101(2):130-5. PubMed ID: 11683571
[TBL] [Abstract][Full Text] [Related]
11. Defective expression and function of the leukocyte associated Ig-like receptor 1 in B lymphocytes from systemic lupus erythematosus patients.
Colombo BM; Canevali P; Magnani O; Rossi E; Puppo F; Zocchi MR; Poggi A
PLoS One; 2012; 7(2):e31903. PubMed ID: 22355402
[TBL] [Abstract][Full Text] [Related]
12. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells.
Halcomb KE; Musuka S; Gutierrez T; Wright HL; Satterthwaite AB
Mol Immunol; 2008 Dec; 46(2):233-41. PubMed ID: 18849077
[TBL] [Abstract][Full Text] [Related]
13. CXCR5 is critically involved in progression of lupus through regulation of B cell and double-negative T cell trafficking.
Wiener A; Schippers A; Wagner N; Tacke F; Ostendorf T; Honke N; Tenbrock K; Ohl K
Clin Exp Immunol; 2016 Jul; 185(1):22-32. PubMed ID: 26990531
[TBL] [Abstract][Full Text] [Related]
14. Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients.
Rodríguez-Bayona B; Ramos-Amaya A; Pérez-Venegas JJ; Rodríguez C; Brieva JA
Arthritis Res Ther; 2010; 12(3):R108. PubMed ID: 20525218
[TBL] [Abstract][Full Text] [Related]
15. Expression of B cell receptor-associated signaling molecules in human lupus.
Huck S; Le Corre R; Youinou P; Zouali M
Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
[TBL] [Abstract][Full Text] [Related]
16. Altered B cell receptor signaling in human systemic lupus erythematosus.
Jenks SA; Sanz I
Autoimmun Rev; 2009 Jan; 8(3):209-13. PubMed ID: 18723129
[TBL] [Abstract][Full Text] [Related]
17. Plasmablast-like Phenotype Among Antigen-Experienced CXCR5-CD19
Szelinski F; Stefanski AL; Schrezenmeier E; Rincon-Arevalo H; Wiedemann A; Reiter K; Ritter J; Lettau M; Dang VD; Fuchs S; Frei AP; Alexander T; Lino AC; Dörner T
Arthritis Rheumatol; 2022 Sep; 74(9):1556-1568. PubMed ID: 35507291
[TBL] [Abstract][Full Text] [Related]
18. [The abnormality of FcgammaRIIB1-mediated signaling and the hyperactivity of B cells from patients with systemic lupus erythematosus].
Peng KJ; Xiao LS; Fei Y; Wang SR
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Nov; 22(6):769-71. PubMed ID: 17077019
[TBL] [Abstract][Full Text] [Related]
19. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
[TBL] [Abstract][Full Text] [Related]
20. B-cell subsets, signaling and their roles in secretion of autoantibodies.
Iwata S; Tanaka Y
Lupus; 2016 Jul; 25(8):850-6. PubMed ID: 27252261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
